Valneva SE
VLA
ISIN FR0004056851 / Valor 1184169
Valneva SE
UMushroom community rating:
About company
Valneva SE is a biotechnology firm dedicated to the development, manufacturing, and commercialization of preventive vaccines for infectious diseases that lack adequate medical solutions. The company has successfully launched three vaccines, including a single-dose chikungunya vaccine, and is actively progressing a diverse pipeline of candidates aimed at diseases such as Lyme disease, Shigella, and Zika virus. By leveraging its specialized expertise in vaccine technology, Valneva focuses on addressing significant public health needs through innovative vaccine development, positioning itself as a key player in the global efforts to prevent and control infectious diseases.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
471 M
Market cap (USD)
1,007,350
Daily traded volume (Shares)
2.198 / 2.088
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
